Revascularization for multivessel disease: Getting closer, but…
- PMID: 32652848
- DOI: 10.1002/ccd.29087
Revascularization for multivessel disease: Getting closer, but…
Abstract
In a registry, it is all about any differences. PCI and CABG for multivessel disease are comparable with regard to risk of death/MI/stroke, but PCI has a significantly higher risk of return to Cath Lab for PCI or even CABG in follow-up.
© 2020 Wiley Periodicals LLC.
Comment on
-
Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).Catheter Cardiovasc Interv. 2020 Jul;96(1):42-51. doi: 10.1002/ccd.28420. Epub 2019 Aug 7. Catheter Cardiovasc Interv. 2020. PMID: 31389659
References
REFERENCES
-
- Hartzler GO. Coronary angioplasty is the treatment of choice for multivessel coronary artery disease. Chest. 1986;90:877-887.
-
- Stone GW, Kappetein AP, Sabik JF, et al. Five-year outcomes after PCI or CABG for left Main coronary disease. NEJM. 2019;381:1820-1830.
-
- Li G, Sajobi TT, Menon BK, et al. Registry-based randomized controlled trials-what are the advantages, challenges, and areas for future research? 2016 symposium on registry-based randomized controlled trials in Calgary. J Clin Epidemiol. 2016;80:16-24.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
